Pharmaceutical containing dendritic cells, and method for producing same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10022401
SERIAL NO

15121557

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

[Problem] The purpose of the present invention is to provide a novel pharmaceutical for use in cellular immunotherapy for the prevention and/or treatment of diseases in which Th2-type cytokines are effective, such as cardiovascular disease and the like.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYSAPPORO-SHI HOKKAIDO 060-0808

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ishimori, Naoki Sapporo, JP 2 0
Kinugawa, Shintaro Sapporo, JP 2 0
Saito, Akimichi Sapporo, JP 2 0
Tsutsui, Hiroyuki Sapporo, JP 8 20

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 17, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 17, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00